Multidrug-resistant ESBL-producing Enterobacteriaceae and associated risk factors in community infants in Lebanon

Soumaya Moustafa Hijazi1, Mohamad Anwar Fawzi, Faten Moustafa Ali

  • 1Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon. somayahijazi@yahoo.com.

Insights

This study found nearly half of Lebanese infants carry extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE). Factors like male gender, hospital birth, and formula feeding increase colonization, with CTX-M-9 being the most common gene.

Area of Science:

  • Microbiology
  • Pediatrics
  • Public Health

Background:

  • Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) pose a growing threat to pediatric health.
  • Infant fecal flora serves as a reservoir for ESBLs, necessitating investigation into community-level colonization.

Purpose of the Study:

  • To investigate rectal colonization rates of ESBL-PE in Lebanese community infants.
  • To identify associated risk factors, antimicrobial susceptibility, and molecular characteristics of ESBL-PE.

Main Methods:

  • Rectal swabs collected from 117 infants aged 1-12 months.
  • ESBL detection via double-disk synergy, combination-disk method, and multiplex PCR.
  • Risk factor assessment using a standardized questionnaire.

Main Results:

  • 58% (49.6%) of infants were ESBL-PE carriers.
  • Significant risk factors included male gender, hospital birth, C-section delivery, and formula feeding.
  • Multiple bla gene carriage was common, with CTX-M types (especially CTX-M-9) predominating.

Conclusions:

  • This is the first study on ESBL-PE carriage in Lebanese community infants, providing crucial regional data.
  • Hospital birth, C-section, and formula feeding are significant risk factors for colonization in non-hospitalized infants.
  • The study highlights widespread CTX-M-9 ESBL dissemination and multiple resistance gene carriage.
Abstract

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
631
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349